サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1775072

心筋内膜生検の世界市場

Endomyocardial Biopsy

出版日
ページ情報
英文 381 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
心筋内膜生検の世界市場
出版日: 2025年07月23日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 381 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心筋内膜生検の世界市場は2030年までに4億7,770万米ドルに達する見込み

2024年に3億5,590万米ドルと推定される心筋内膜生検の世界市場は、2024年から2030年にかけてCAGR 5.0％で成長し、2030年には4億7,770万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである鉗子は、CAGR 4.0％を記録し、分析期間終了時には2億9,450万米ドルに達すると予測されています。アクセサリー分野の成長率は、分析期間中CAGR 6.8％と推定されます。

米国市場は9,700万米ドルと推定、中国はCAGR 7.8％で成長予測

米国の心筋内膜生検市場は、2024年には9,700万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 7.8%で推移し、2030年には予測市場規模9,390万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5％と5.0％と予測されています。欧州では、ドイツがCAGR 3.2%で成長すると予測されています。

世界の心筋内膜生検市場- 主要動向と促進要因のまとめ

なぜ心筋内膜生検は心臓診断において重要な手順なのか？

心筋内膜生検（EMB）は、心筋炎、心臓移植の拒絶反応、心筋症、アミロイドーシスやサルコイドーシスなどの浸潤性心疾患の診断に使用される低侵襲の手技です。この手技は心臓組織の病態を評価し、治療方針を決定し、移植後の心機能をモニターするために不可欠です。心不全、自己免疫性心疾患、ウイルス感染による合併症（COVID-19関連心筋炎など）の有病率の上昇に伴い、EMBの需要は世界的に増加しています。

インターベンショナル心臓病学および精密診断学の拡大が、心臓研究や個別化医療におけるEMBの使用をさらに後押ししています。さらに、生検カテーテル設計、ロボット支援心臓インターベンション、AIを活用した病理解析の進歩により、手技精度が向上し、合併症発生率が低下しています。心疾患が世界的に死亡率の主要因であり続ける中、EMBは心筋障害の早期かつ正確な診断のためのゴールドスタンダードになりつつあります。

心筋内膜生検における主な技術的進歩とは？

EMBにおける最近の進歩には、ロボットガイド下生検カテーテル、AIによる組織分析、低侵襲経橈骨アクセス技術などがあります。柔軟性を高めたマイクロ生検鉗子の開発により、心室穿孔や生検後の不整脈のリスクが減少しました。さらに、3D画像支援生検ナビゲーションは、生検の精度とリアルタイムの組織特性を改善し、移植拒絶反応や炎症状態の早期発見を可能にしました。

もう1つの重要な技術革新は、心血管疾患診断におけるリキッドバイオプシー技術の利用であり、場合によっては侵襲的処置の必要性を減らすことができます。さらに、自動化された組織処理とAIによる病理組織学的分析が生検の解釈を強化し、診断精度と治療成績を向上させています。遠隔医療と遠隔病理診察の統合も、特に農村部や過疎地におけるEMBの利用可能性の拡大に貢献しています。

心筋内膜生検市場の成長の原動力は？

心筋内膜生検市場の成長の原動力は、心血管疾患有病率の上昇、低侵襲心臓インターベンションの進歩、心臓画像診断および生検技術の向上です。心臓移植手術の増加や移植後のモニタリングプロトコールが、生検ベースの心臓評価に対する需要を煽っています。さらに、心筋症、ウイルス性心筋炎、薬剤誘発性心毒性などの調査拡大により、臨床試験や製薬研究におけるEMBの利用が増加しています。

生分解性およびナノテクノロジーに基づく生検カテーテル、AIを活用した心臓組織分析、ロボット支援生検システムの出現は、市場展望を再定義すると予想されます。心疾患の早期発見と精密医療を推進する政府とヘルスケアの取り組みがさらに成長に寄与しています。心不全症例が世界的に増加するにつれ、正確なリアルタイムの心筋組織診断に対する需要が急増し、将来の心臓治療におけるEMBの重要性が強化されると予想されます。

セグメント

製品（鉗子、アクセサリー）;先端（マキシカーブ、ストレート、プレカーブ、その他）;エンドユース（病院、外来手術センター、その他）

調査対象企業の例

  • Abbott Laboratories
  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cook Medical
  • Cordis
  • Edwards Lifesciences Corporation
  • HEARTROID
  • Johnson & Johnson（Ethicon）
  • Medtronic plc
  • Mermaid Medical Group
  • Olympus Corporation
  • Philips Healthcare
  • Scholten Surgical Instruments, Inc.
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Technowood International Pte Ltd
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30778

Global Endomyocardial Biopsy Market to Reach US$477.7 Million by 2030

The global market for Endomyocardial Biopsy estimated at US$355.9 Million in the year 2024, is expected to reach US$477.7 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Forceps, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$294.5 Million by the end of the analysis period. Growth in the Accessories segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$97.0 Million While China is Forecast to Grow at 7.8% CAGR

The Endomyocardial Biopsy market in the U.S. is estimated at US$97.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$93.9 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Endomyocardial Biopsy Market - Key Trends & Drivers Summarized

Why Is Endomyocardial Biopsy a Critical Procedure in Cardiac Diagnostics?

Endomyocardial biopsy (EMB) is a minimally invasive procedure used to diagnose myocarditis, cardiac transplant rejection, cardiomyopathies, and infiltrative heart diseases such as amyloidosis and sarcoidosis. This procedure is essential in assessing cardiac tissue pathology, guiding treatment decisions, and monitoring post-transplant heart function. With the rising prevalence of heart failure, autoimmune cardiac conditions, and complications from viral infections (e.g., COVID-19-associated myocarditis), the demand for EMB has increased globally.

The expansion of interventional cardiology and precision diagnostics has further boosted the use of EMB in cardiac research and personalized medicine. Additionally, advancements in biopsy catheter design, robotic-assisted cardiac interventions, and AI-powered pathology analysis have improved procedural accuracy and reduced complication rates. As cardiac diseases continue to be a leading cause of mortality worldwide, EMB is becoming a gold standard for early and precise diagnosis of myocardial disorders.

What Are the Key Technological Advancements in Endomyocardial Biopsy?

Recent advancements in EMB include robotic-guided biopsy catheters, AI-enhanced tissue analysis, and minimally invasive transradial access techniques. The development of micro-biopsy forceps with enhanced flexibility has reduced the risk of ventricular perforation and post-biopsy arrhythmias. Additionally, 3D imaging-assisted biopsy navigation has improved biopsy accuracy and real-time tissue characterization, allowing for earlier detection of transplant rejection and inflammatory conditions.

Another key innovation is the use of liquid biopsy techniques in cardiovascular disease diagnostics, reducing the need for invasive procedures in some cases. Furthermore, automated tissue processing and AI-driven histopathological analysis are enhancing biopsy interpretation, improving diagnostic precision and treatment outcomes. The integration of telemedicine and remote pathology consultations is also helping to expand EMB accessibility, particularly in rural and underdeveloped regions.

What Is Driving the Growth of the Endomyocardial Biopsy Market?

The growth in the endomyocardial biopsy market is driven by rising cardiovascular disease prevalence, advancements in minimally invasive cardiac interventions, and improvements in cardiac imaging and biopsy technologies. The increasing number of heart transplant procedures and post-transplant monitoring protocols has fueled demand for biopsy-based cardiac assessment. Additionally, expanding research in cardiomyopathies, viral myocarditis, and drug-induced cardiac toxicity has increased EMB utilization in clinical trials and pharmaceutical research.

The emergence of biodegradable and nanotechnology-based biopsy catheters, AI-powered cardiac tissue analysis, and robotic-assisted biopsy systems is expected to redefine the market landscape. Government and healthcare initiatives promoting early cardiac disease detection and precision medicine are further contributing to growth. As heart failure cases rise worldwide, the demand for accurate, real-time myocardial tissue diagnostics is expected to surge, reinforcing the importance of EMB in the future of cardiac care.

SCOPE OF STUDY:

The report analyzes the Endomyocardial Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Forceps, Accessories); Tip (Maxi-curved, Straight, Pre-curved, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cook Medical
  • Cordis
  • Edwards Lifesciences Corporation
  • HEARTROID
  • Johnson & Johnson (Ethicon)
  • Medtronic plc
  • Mermaid Medical Group
  • Olympus Corporation
  • Philips Healthcare
  • Scholten Surgical Instruments, Inc.
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Technowood International Pte Ltd
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Endomyocardial Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Heart Transplants and Myocarditis Drives Growth in Endomyocardial Biopsy Procedures
    • Need for Accurate Post-Transplant Rejection Monitoring Sustains Use of Endomyocardial Biopsy as Gold Standard
    • Integration of Biopsy With Imaging-Guided Catheterization Improves Diagnostic Accuracy and Patient Safety
    • Advancements in Biopsy Forceps Design Reduce Risk of Perforation and Sampling Errors
    • Increased Cardiologist Training and Protocol Standardization Support Wider Biopsy Adoption in Heart Centers
    • Growth in Cardiac Research Trials Fuels Demand for Endomyocardial Biopsy as a Study Endpoint
    • Hospital Investment in Advanced Electrophysiology Labs Supports Infrastructure for Biopsy Procedures
    • Demand for Early Diagnosis of Inflammatory Cardiomyopathies Propels Use of Targeted Biopsy Devices
    • Development of Genomic and Molecular Analysis Tools Enhances Value of Biopsy Tissue Samples
    • Rising Use of Biopsy in Rare Cardiovascular Conditions Like Sarcoidosis Expands Procedural Volume
    • Clinical Guidelines Reinforce Role of Endomyocardial Biopsy in Unexplained Heart Failure Evaluation
    • Innovation in Steerable Biopsy Catheters Increases Precision in Hard-to-Reach Myocardial Zones
    • Increased Awareness of Autoimmune and Viral Cardiac Conditions Promotes Biopsy as a Diagnostic Tool
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Endomyocardial Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Endomyocardial Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Endomyocardial Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Forceps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Forceps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Forceps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Maxi-curved by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Maxi-curved by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Maxi-curved by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Straight by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pre-curved by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pre-curved by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pre-curved by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Tips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Tips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Tips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Endomyocardial Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Endomyocardial Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Endomyocardial Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Endomyocardial Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Endomyocardial Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Endomyocardial Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Endomyocardial Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Endomyocardial Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Endomyocardial Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Product - Forceps and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Endomyocardial Biopsy by Product - Forceps and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Endomyocardial Biopsy by Product - Percentage Breakdown of Value Sales for Forceps and Accessories for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Endomyocardial Biopsy by Tip - Maxi-curved, Straight, Pre-curved and Other Tips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Endomyocardial Biopsy by Tip - Percentage Breakdown of Value Sales for Maxi-curved, Straight, Pre-curved and Other Tips for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Endomyocardial Biopsy by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Endomyocardial Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION